Rare diseases and SDG 3
Achieving universal health coverage requires meeting the needs of people with rare diseases, who need more and better medicines, proper diagnosis and lifelong care, social support, and access to assistive technologies.
The United Nations has emphasized the need to:
- Ending preventable deaths of newborns and children under five
- To end preventable mortality caused by non-communicable diseases.
- To achieve universal health coverage support.
- Drug research and development
The burden of rare diseases is considerable, with an estimated 350 million people affected worldwide. It is in the same range as prominent and more “visible” non-communicable diseases such as diabetes.
By fighting for the right to adequate diagnosis and treatment of patients living with a rare disease, we help the current generation and the future one since the vast majority of rare diseases are genetic and, therefore, preventable if invested resources in an appropriate way.
Fonte: NGO Committee for Rare Diseases
Since the Millenium Development Goals (MDG) historic progress has been made in reducing child mortality, improving maternal health, and in the fight against HIV/AIDS, tuberculosis, malaria, and other diseases. In 15 years, the number of people infected with HIV each year has dropped from 3.1 million to 2 million, and more than 6.2 million lives have been saved from malaria.
Despite progress, chronic diseases and those resulting from disasters remain the main factors contributing to poverty and deprivation of the most vulnerable. Currently, 63% of all deaths come from non-communicable diseases, mainly cardiovascular, respiratory, cancer, and diabetes. Economic losses to low- and middle-income countries from these diseases are estimated to exceed US$7 trillion by 2025.
The SDGs propose integrated goals that address promoting health and well-being as essential to advancing human capacities.
Get to know SDG 3 and its targets
|3.1||By 2030, reduce the global maternal mortality ratio to less than 70 per 100,000 live births|
|3.2||By 2030, end preventable deaths of newborns and children under 5 years of age, with all countries aiming to reduce neonatal mortality to at least as low as 12 per 1,000 live births and under-5 mortality to at least as low as 25 per 1,000 live births|
|3.3||By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases|
|3.4||By 2030, reduce by one third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being|
|3.5||Strengthen the prevention and treatment of substance abuse, including narcotic drug abuse and harmful use of alcohol|
|3.6||By 2020, halve the number of global deaths and injuries from road traffic accidents|
|3.7||By 2030, ensure universal access to sexual and reproductive health-care services, including for family planning, information and education, and the integration of reproductive health into national strategies and programmes|
|3.8||Achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all|
|3.9||By 2030, substantially reduce the number of deaths and illnesses from hazardous chemicals and air, water and soil pollution and contamination|
|3.a||Strengthen the implementation of the World Health Organization Framework Convention on Tobacco Control in all countries, as appropriate|
|3.b||Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all|
|3.c||Substantially increase health financing and the recruitment, development, training and retention of the health workforce in developing countries, especially in least developed countries and small island developing States|
|3.d||Strengthen the capacity of all countries, in particular developing countries, for early warning, risk reduction and management of national and global health risks|
Do you want to know how Brazil performed on SDG 3 in 2021?
The 2030 Agenda for Sustainable Development: Spotlight Report 2022 Brazil Synthesis, which is the source of our data, is a document prepared by the Working Group of Civil Society for the 2030 Agenda (GT Agenda 2030/GTSC A2030). It analyzes the implementation of the Sustainable Development Goals (SDGs) in Brazil. It shows what the country needs to do to fulfill the commitment it assumed with the UN to reach global goals by 2030.To find out how Brazil performed in SDG 3, click here.